NO20010620L - Vitronektinreseptor-antagonister - Google Patents

Vitronektinreseptor-antagonister

Info

Publication number
NO20010620L
NO20010620L NO20010620A NO20010620A NO20010620L NO 20010620 L NO20010620 L NO 20010620L NO 20010620 A NO20010620 A NO 20010620A NO 20010620 A NO20010620 A NO 20010620A NO 20010620 L NO20010620 L NO 20010620L
Authority
NO
Norway
Prior art keywords
alkyl
het
halogen
6alkyl
co2r9
Prior art date
Application number
NO20010620A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010620D0 (no
Inventor
Peter J Manley
William H Miller
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20010620D0 publication Critical patent/NO20010620D0/no
Publication of NO20010620L publication Critical patent/NO20010620L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20010620A 1998-08-07 2001-02-06 Vitronektinreseptor-antagonister NO20010620L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9570398P 1998-08-07 1998-08-07
PCT/US1999/017665 WO2000007544A2 (en) 1998-08-07 1999-08-03 Vitronectin receptor antagonists

Publications (2)

Publication Number Publication Date
NO20010620D0 NO20010620D0 (no) 2001-02-06
NO20010620L true NO20010620L (no) 2001-02-06

Family

ID=22253229

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010620A NO20010620L (no) 1998-08-07 2001-02-06 Vitronektinreseptor-antagonister

Country Status (18)

Country Link
US (1) US6458814B1 (ko)
EP (1) EP1102587A4 (ko)
JP (1) JP2002522360A (ko)
KR (1) KR20010086355A (ko)
CN (1) CN1322133A (ko)
AR (1) AR020121A1 (ko)
AU (1) AU5336299A (ko)
BR (1) BR9912638A (ko)
CA (1) CA2339666A1 (ko)
CO (1) CO5170532A1 (ko)
CZ (1) CZ2001447A3 (ko)
HU (1) HUP0103090A3 (ko)
IL (1) IL141163A0 (ko)
NO (1) NO20010620L (ko)
PL (1) PL346157A1 (ko)
TR (1) TR200100363T2 (ko)
WO (1) WO2000007544A2 (ko)
ZA (1) ZA200100935B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
DE60130910T2 (de) 2000-04-17 2008-07-10 Ucb Pharma, S.A. Enamin-derivate als zell-adhäsionsmoleküle
JP2004511434A (ja) 2000-06-15 2004-04-15 ファルマシア・コーポレーション インテグリン受容体アンタゴニストとしてのヘテロアリールアルカン酸
FR2847254B1 (fr) * 2002-11-19 2005-01-28 Aventis Pharma Sa Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant
BR0316876A (pt) 2002-12-20 2005-10-25 Pharmacia Corp Compostos de tiazol e composição farmacêutica compreendendo o mesmo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59108771A (ja) * 1982-12-13 1984-06-23 Taiho Yakuhin Kogyo Kk オキサゾール誘導体
FI922867A7 (fi) 1991-06-21 1992-12-22 Tanabe Seiyaku Co Dikarbonsyraderivat och foerfarande foer framstaellning av dem
ATE181735T1 (de) * 1993-05-01 1999-07-15 Merck Patent Gmbh Substituierte 1-phenyl-oxazolidin-2-on derivate, deren herstellung und deren verwendung als adhäsionsrezeptor-antagonisten
US5756466A (en) * 1994-06-17 1998-05-26 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
WO1996000730A1 (en) * 1994-06-29 1996-01-11 Smithkline Beecham Corporation Vitronectin receptor antagonists

Also Published As

Publication number Publication date
AU5336299A (en) 2000-02-28
NO20010620D0 (no) 2001-02-06
ZA200100935B (en) 2002-05-14
TR200100363T2 (tr) 2001-06-21
AR020121A1 (es) 2002-04-10
CA2339666A1 (en) 2000-02-17
EP1102587A4 (en) 2003-03-12
US6458814B1 (en) 2002-10-01
JP2002522360A (ja) 2002-07-23
EP1102587A2 (en) 2001-05-30
CZ2001447A3 (cs) 2001-08-15
IL141163A0 (en) 2002-02-10
HUP0103090A3 (en) 2002-12-28
BR9912638A (pt) 2001-05-02
WO2000007544A3 (en) 2000-05-18
KR20010086355A (ko) 2001-09-10
CN1322133A (zh) 2001-11-14
CO5170532A1 (es) 2002-06-27
PL346157A1 (en) 2002-01-28
HUP0103090A2 (hu) 2002-01-28
WO2000007544A2 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
AU2005286592A1 (en) Novel pyrimidine compounds, process for their preparation and compositions containing them
PE20220597A1 (es) Inhibidores de la autofagia de fenilaminopirimidina amida y metodos de uso de estos
ES2567047T3 (es) Derivados de pirimidina anti-virales
ES2244469T3 (es) Fenilpiperazinas como inhibidores de la recaptacion de serotonina.
NO341631B1 (no) Hydroksybenzamidderivater og deres anvendelse, fremgangsmåte for fremstilling og farmasøytiske sammensetninger
DK0773943T3 (da) Forbindelser, der er anvendelige som antiproliferative midler og garft-inhibitorer
DK2343281T3 (en) Process for the Synthesis of Phenoxydiamino-Pyrimidine Derivatives
MXPA05002839A (es) Derivados de 1-piridin-4-il-urea.
AR071314A1 (es) Antagonistas de receptor de cgrp
PT1533304E (pt) Derivado de amida
NO20062489L (no) Heterocykliske anti-migrenemidler
PE20070462A1 (es) Compuestos derivados de fenilaminopropanol
BRPI0710121A2 (pt) compostos, processos para a fabricação de compostos; composições farmacêuticas; método para o tratamento e/ou prevenção de doenças associadas à modulação de receptores de sst subtipo 5 e uso de compostos
CY1114932T1 (el) Αντιπαρασιτικοι παραγοντες
AR052866A1 (es) Fenil-metanonas monociclicas sustituidas
RU2011125917A (ru) Производные фенилпиримидона, фармацевтические композиции, способы их получения и применения
PE20080077A1 (es) Derivados de sulfonilfenilo como antagonistas del receptor de il-8
AR035759A1 (es) Compuestos acilurea antagonistas de la funcion mpc-1, un procedimiento para su preparacion, composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
TNSN06203A1 (en) Derivatives of n- (1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity
PE20091243A1 (es) Compuesto heterociclico fusionado
AR029400A1 (es) Derivados de isoxazolcarboxamida, un metodo para su preparacion y una composicion farmaceutica que los comprende
HRP20080274T3 (en) 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
NO20072444L (no) Karbamatforbindelser for anvendelse i behandling av neurodegenerative forstyrrelser
JP2008542221A (ja) レニン阻害剤としての置換ピペリジン
AR047958A1 (es) Derivados de 1-bencil-5-piperazin-1-il-3,4 dihidro-1h-quinazolin-2-ona y sus derivados 1h-benzo(1,2,6)tiadiazina-2,2-dioxidos y 1,4-dihidro-benzo(d)(1,3)oxazinas-2-ona,como moduladores del receptor 5-ht,para el tratamiento de enfermedades del sistema nervioso central.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application